Lara et al used clinical, radiological, and pleural fluid findings to evaluate a pleural effusion. The authors are from La Fe University, University of Valencia, research centers and affiliated hospitals in Spain.
Patient selection: pleural effusion
Parameters:
(1) lung mass
(2) pleural thickening
(3) dyspnea
(4) history of cancer
(5) LDH in IU/L in pleural fluid
(6) pH in pleural fluid
Tree Diagram 1
Mass |
Pleural Thickening |
Dyspnea |
History of Cancer |
Endpoint |
no |
no |
NA |
NA |
1 |
no |
yes |
NA |
NA |
2 |
yes |
NA |
no |
NA |
3 |
yes |
NA |
yes |
no |
4 |
yes |
NA |
yes |
yes |
5 |
Tree Diagram 2
Mass |
LDH |
Dyspnea |
pH |
Endpoint |
no |
<= 169 |
NA |
NA |
6 |
no |
> 169 |
yes |
NA |
7 |
no |
> 169 |
no |
NA |
8 |
yes |
NA |
NA |
>= 7.38 |
9 |
yes |
NA |
NA |
< 7.38 |
10 |
Endpoint |
Malignant |
Paramalignant |
Benign |
1 |
28.6% |
5.7% |
65.7% |
2 |
77.8% |
0% |
22.2% |
3 |
22.2% |
77.8% |
0% |
4 |
78.6% |
21.4% |
0% |
5 |
25% |
75% |
0% |
6 |
8.3% |
0% |
91.7 |
7 |
65.2% |
4.3% |
30.4% |
8 |
11.1% |
11.1% |
77.8% |
9 |
26.7% |
73.3% |
0% |
10 |
53.3% |
16.7% |
0% |
where:
• It is interesting that a personal history of cancer in endpoint 5 is associated with a lower risk of cancer than its absence (endpoint 4).
The addition of cytology findings would be helpful in narrowing the diagnosis.
Specialty: Pulmonology